These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31699501)

  • 1. Global harmonization of vaccine testing requirements: Making elimination of the ATT and TABST a concrete global achievement.
    Viviani L; Halder M; Gruber M; Bruckner L; Cussler K; Sanyal G; Srinivas G; Goel S; Kaashoek M; Litthauer D; Lopes da Silva AL; Sakanyan E; Aprea P; Jin H; Vandeputte J; Seidle T; Yakunin D
    Biologicals; 2020 Jan; 63():101-105. PubMed ID: 31699501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Future of TABST and LABST in the Indian Pharmacopoeia Monographs A Humane Society International/India Workshop Report.
    Poojary B; Viviani L; Sengupta A; Kalaivani M; Verma SR; Teng V; Makhija V; Prakash R; Bhatia N; Singh SN; Bruckner L; Halder M; Vree J
    Biologicals; 2023 Aug; 83():101665. PubMed ID: 37244127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerating Global Deletion of the Abnormal Toxicity Test for vaccines and biologicals. Planning common next steps. A workshop Report.
    Viviani L; Reid K; Gastineau T; Milne C; Smith D; Levis R; Lei D; van Ooij M; Gilbert PA; Vandeputte J; Xie J; Madhuri L; Shaid S; Kubiak V; Suri R; Mizukami T; Shirasaki Y; Li X; Zhou YY; Trapkova A; Goel S; Prakash J; Subagio AA; Suwarni E; Jung KJ; Sanyal G; Das P; Coppens E; Wright D; Peng Z; Northeved H; Jungbäck C; Kirpitchenok T; Del Pace L; Seo B; Poojary B; Ottoni A
    Biologicals; 2022 Jul; 78():17-26. PubMed ID: 35840492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three Rs Approaches in the Production and Quality Control of Fish Vaccines.
    Midtlyng PJ; Hendriksen C; Balks E; Bruckner L; Elsken L; Evensen O; Fyrand K; Guy A; Halder M; Hawkins P; Kisen G; Romstad AB; Salonius K; Smith P; Sneddon LU
    Biologicals; 2011 Mar; 39(2):117-28. PubMed ID: 21371907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Historical data analyses and scientific knowledge suggest complete removal of the abnormal toxicity test as a quality control test.
    Garbe JHO; Ausborn S; Beggs C; Bopst M; Joos A; Kitashova AA; Kovbasenco O; Schiller CD; Schwinger M; Semenova N; Smirnova L; Stodart F; Visalli T; Vromans L
    J Pharm Sci; 2014 Nov; 103(11):3349-3355. PubMed ID: 25209378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three Rs potential in the development and quality control of immunobiologicals.
    Halder M
    ALTEX; 2001; 18 Suppl 1():13-47. PubMed ID: 11854853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The consistency approach for quality control of vaccines - a strategy to improve quality control and implement 3Rs.
    De Mattia F; Chapsal JM; Descamps J; Halder M; Jarrett N; Kross I; Mortiaux F; Ponsar C; Redhead K; McKelvie J; Hendriksen C
    Biologicals; 2011 Jan; 39(1):59-65. PubMed ID: 21277791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards eliminating the use of animals for regulatory required vaccine quality control.
    Hendriksen CF
    ALTEX; 2006; 23(3):187-90. PubMed ID: 17086348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal testing for vaccines. Implementing replacement, reduction and refinement: challenges and priorities.
    Akkermans A; Chapsal JM; Coccia EM; Depraetere H; Dierick JF; Duangkhae P; Goel S; Halder M; Hendriksen C; Levis R; Pinyosukhee K; Pullirsch D; Sanyal G; Shi L; Sitrin R; Smith D; Stickings P; Terao E; Uhlrich S; Viviani L; Webster J
    Biologicals; 2020 Nov; 68():92-107. PubMed ID: 33041187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humane Society International's global campaign to end animal testing.
    Seidle T
    Altern Lab Anim; 2013 Dec; 41(6):453-9. PubMed ID: 24512229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3Rs implementation in veterinary vaccine batch-release testing: Current state-of-the-art and future opportunities. A webinar and workshop report.
    Viviani L; Balks E; Beken S; Brady AM; Clayton R; Cliquet F; Desmayanti L; Fragoeiro S; Hamtak TJ; John D; Jungbaëck C; Kalaivani M; Kross I; Lang C; Ria Isriyanthi NM; Mallet L; Milne C; Rubbrecht M; Siklódi B; Singh B; Srinivas GB; Stickings P; Stirling C; Sundram P; Szabó M; Thomas A; van den Berg M; Walker A; Philippe C; Vandeputte J
    Biologicals; 2023 Aug; 83():101695. PubMed ID: 37516084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing the use of the target animal batch safety test for veterinary vaccines.
    Roberts B; Lucken RN
    Dev Biol Stand; 1996; 86():97-102. PubMed ID: 8785997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modern science for better quality control of medicinal products "Towards global harmonization of 3Rs in biologicals": The report of an EPAA workshop.
    Schutte K; Szczepanska A; Halder M; Cussler K; Sauer UG; Stirling C; Uhlrich S; Wilk-Zasadna I; John D; Bopst M; Garbe J; Glansbeek HL; Levis R; Serreyn PJ; Smith D; Stickings P
    Biologicals; 2017 Jul; 48():55-65. PubMed ID: 28596049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replacement, Reduction, Refinement - Animal welfare progress in European Pharmacopoeia monographs: activities of the European Pharmacopoeia Commission from 2007 to 2017.
    Lang C; Kolaj-Robin O; Cirefice G; Taconet L; Pel E; Jouette S; Buda M; Milne C; Charton E
    Pharmeur Bio Sci Notes; 2018; 2018():12-36. PubMed ID: 29845933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replacement, reduction or refinement of animal use in the quality control of veterinary vaccines: development, validation and implementation.
    van der Kamp MD
    Dev Biol Stand; 1996; 86():73-6. PubMed ID: 8785994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An expert consortium review of the EC-commissioned report "alternative (Non-Animal) methods for cosmetics testing: current status and future prospects - 2010".
    Hartung T; Blaauboer BJ; Bosgra S; Carney E; Coenen J; Conolly RB; Corsini E; Green S; Faustman EM; Gaspari A; Hayashi M; Wallace Hayes A; Hengstler JG; Knudsen LE; Knudsen TB; McKim JM; Pfaller W; Roggen EL
    ALTEX; 2011; 28(3):183-209. PubMed ID: 21993956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The vaccines consistency approach project: an EPAA initiative.
    De Mattia F; Hendriksen C; Buchheit KH; Chapsal JM; Halder M; Lambrigts D; Redhead K; Rommel E; Scharton-Kersten T; Sesardic T; Viviani L; Ragan I
    Pharmeur Bio Sci Notes; 2015; 2015():30-56. PubMed ID: 26830158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ECVAM's contributions to the implementation of the Three Rs in the production and quality control of biologicals.
    Halder M; Hendriksen C; Cussler K; Balls M
    Altern Lab Anim; 2002; 30(1):93-108. PubMed ID: 11827574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardisation of defined approaches for skin sensitisation testing to support regulatory use and international adoption: position of the International Cooperation on Alternative Test Methods.
    Casati S; Aschberger K; Barroso J; Casey W; Delgado I; Kim TS; Kleinstreuer N; Kojima H; Lee JK; Lowit A; Park HK; Régimbald-Krnel MJ; Strickland J; Whelan M; Yang Y; Zuang V
    Arch Toxicol; 2018 Feb; 92(2):611-617. PubMed ID: 29127450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress and future directions for reduction, refinement, and replacement of animal use in veterinary vaccine potency and safety testing: a report from the 2010 NICEATM-ICCVAM International Vaccine Workshop.
    Stokes WS; Kulpa-Eddy J; Brown K; Srinivas G; McFarland R
    Dev Biol (Basel); 2012; 134():9-21. PubMed ID: 22888590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.